文献速递传染病防控与疫情报告免疫规划

2017年新加坡长期护理机构流感暴发期间流感疫苗效果评估

Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore's long term care facilities, 2017.
PubMed 文献 · Vaccine · 2019-05-31

该研究采用检测阴性设计评估2017年新加坡长期护理机构流感暴发期间流感疫苗效果,纳入264人,其中118例实验室确诊流感。总体调整疫苗效果为40.5%(95%CI:-12.2-68.5%),对A(H3N2)为57.1%(95%CI:5.7-80.5%),接种后15-180天效果更高。

要点

  • 总体调整VE为40.5%,对A(H3N2)VE为57.1%,对A(H1N1)pdm09无显著保护。
  • 接种后15-180天调整VE对全部流感为59.3%,对A(H3N2)为67.9%。
  • 接种后181-365天估计值均不显著,近期接种保护更好。

核心结论

  • 流感疫苗在2017年新加坡长期护理机构中显示 varying 效果,近期接种者效果更高。
  • 疫苗仍是预防流感感染的重要工具,尤其对高危人群。

研究设计与样本

  • 检测阴性设计,评估2017年新加坡卫生部报告的长期护理机构呼吸道暴发中流感疫苗效果。
  • 纳入264人,其中118例实验室确诊流感(32例A(H1N1)pdm09、75例A(H3N2)、11例A未分型),无人感染乙型流感。
  • 采用逻辑回归调整年龄组、性别、发病月份和发病至采样天数。

主要发现

  • 总体调整VE为40.5%(95%CI:-12.2-68.5%)。
  • 亚型调整VE:A(H1N1)pdm09为-43.4%(95%CI:-312.4-50.2%),A(H3N2)为57.1%(95%CI:5.7-80.5%)。
  • 接种后15-180天调整VE:全部流感59.3%(95%CI:18.0-79.8%),A(H1N1)pdm09 35.4%(95%CI:-123.5-81.3%),A(H3N2) 67.9%(95%CI:22.5-86.7%)。
  • 接种后181-365天估计值均不显著。

临床怎么用

  • 在长期护理机构流感暴发中,应优先确保近期接种流感疫苗以提升保护效果。
  • 对高危人群仍需强调流感疫苗接种作为预防流感相关并发症的重要工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Influenza outbreaks occur periodically in Long Term Care Facilities (LTCFs) and vaccination is critical in preventing influenza infections. We evaluated the influenza vaccine effectiveness (VE) during respiratory outbreaks in LTCFs reported to the Ministry of Health, Singapore in 2017. A test-negative design was used to estimate the ratio of the odds of testing positive for influenza among vaccinated individuals to the odds among unvaccinated individuals. The VE was calculated as (1-odds ratio) × 100%. For adjusted VE, the estimates were derived using logistic regression adjusted for age group, gender, month of illness, and number of days from date of illness onset till to swab collection date. Estimates by influenza subtypes and post-vaccination time periods (15-180 days & 181-365 days) were also calculated using stratified data. 264 individuals, with 118 laboratory-confirmed influenza cases [32 A(H1N1)pdm09, 75 A(H3N2), 11 A(untypable)], were included in the analysis. No one was identified to be infected with influenza B. The overall adjusted VE estimate was 40.5% (95% CI: -12.2-68.5%), while the subtype-specific adjusted VE estimates were -43.4% (95% CI: -312.4-50.2%) against A(H1N1)pdm09 and 57.1% (95% CI: 5.7-80.5%) against A(H3N2). At 15-180 days post-vaccination period, the adjusted VEs were 59.3% (95% CI: 18.0-79.8%) against all influenza, 35.4% (95% CI: -123.5-81.3%) against A(H1N1)pdm09 and 67.9% (95% CI: 22.5-86.7%) against A(H3N2). Estimates were not significant at 181-365 days post-vaccination. The influenza vaccine showed varying effectiveness among individuals in Singapore's LTCFs in 2017, with a higher effectiveness among those who were more recently vaccinated. It remains an important tool in preventing influenza infections, especially for those who are at high risk of influenza-related complications.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ng Y, Nandar K, Chua LAV, et al. Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore's long term care facilities, 2017. Vaccine. 2019. PMID: 31160102. doi:10.1016/j.vaccine.2019.03.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。